Apple's desktop OS desperately needs to catch up with its top-notch hardware. Here are the upgrades that could make me to ...
The history of computing is littered with the remains of forgotten operating systems—some rendered obsolete by technological ...
The chipmaker's latest laptop-centric Arm processors, designed for models $300 and up, launch at Computex. They leverage the company's strengths in phone processors.
Although Linux is the king of open-source OSes, there are options. Here you'll find a few open-source OSes to toy around with. Don't expect any of these to be viable options for daily use. When you ...
There are trillions of bacteria that live in your colon. Most of them are harmless and many are actually helpful, supporting digestion and keeping your immune system strong. C. diff is one type of ...
There are about half a million C. diff infections every year in the United States. About 30,000 people die from them annually. But if you’ve had C. diff, you’re more likely to get it again. About 1 in ...
Prompt treatment with fecal transplant can improve survival among critically ill C. difficile patients 14 of 18 patients with life-threatening C. diff survived after a fecal transplant Antibiotics ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. An autonomous agent found, analyzed and exploited a FreeBSD kernel vulnerability in four ...
DEAR DR. ROACH: I read your recent column about a person who was refusing antibiotics due to a fear of a Clostridioides difficile (C. diff) recurrence. I am interested in your thoughts regarding ...
Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of strep throat from Mundo’s first-grade class — routine enough, treatable with ...
An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile, the leading cause of healthcare and antibiotic-associated diarrhea in the US and ...
SAN DIEGO--(BUSINESS WIRE)--Turquoise Health (“Turquoise”), a multi-sided healthcare pricing and payment platform, today announced it has raised $40 million in Series C funding. The round was led by ...